Td Private Client Wealth LLC Novartis Ag Transaction History

Td Private Client Wealth LLC

$4.07 Trillion
Q2 2025

A detailed history of Td Private Client Wealth LLC transactions in Novartis Ag stock. As of the latest transaction made, Td Private Client Wealth LLC holds 12,307 shares of NVS stock, worth $1.63 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

12,307

Previous 12,435 1.03%

Holding current value

$1.63 Million

Previous $1.39 Billion 7.43%

% of portfolio

0.04%

Previous 0.04%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 15, 2025	SELL	$101.96 - $121.01 $13,050 - $15,489	-128 Reduced 1.03%	12,307 $1.49 Billion
Q1 2025 Apr 29, 2025	SELL	$97.14 - $115.57 $14,085 - $16,757	-145 Reduced 1.15%	12,435 $1.39 Billion
Q4 2024 Feb 11, 2025	BUY	$96.78 - $117.18 $12,968 - $15,702	134 Added 1.08%	12,580 $1.22 Billion
Q3 2024 Nov 18, 2024	BUY	$106.13 - $120.89 $381,643 - $434,720	3,596 Added 40.63%	12,446 $1.43 Billion
Q2 2024 Aug 14, 2024	BUY	$92.57 - $107.37 $819,244 - $950,224	8,850 New	8,850 $942 Million
Q1 2024 Aug 16, 2024	SELL	$95.27 - $108.47 $97,747 - $111,290	-1,026 Reduced 8.6%	10,906 $1.05 Billion
Q4 2023 Aug 16, 2024	BUY	$92.27 - $101.54 $58,037 - $63,868	629 Added 5.56%	11,932 $1.2 Billion
Q3 2023 Aug 16, 2024	BUY	$94.73 - $105.13 $176,008 - $195,331	1,858 Added 19.67%	11,303 $1.15 Billion
Q2 2023 Aug 16, 2024	BUY	$92.52 - $104.91 $4,996 - $5,665	54 Added 0.58%	9,445 $953 Million
Q1 2023 Aug 16, 2024	SELL	$80.03 - $92.81 $252,574 - $292,908	-3,156 Reduced 25.15%	9,391 $864 Million
Q4 2022 Aug 16, 2024	BUY	$75.55 - $92.52 $57,720 - $70,685	764 Added 6.48%	12,547 $1.14 Billion
Q3 2022 Aug 16, 2024	SELL	$74.61 - $87.26 $240,468 - $281,238	-3,223 Reduced 21.48%	11,783 $896 Million
Q2 2022 Aug 16, 2024	BUY	$80.52 - $93.75 $141,393 - $164,625	1,756 Added 13.25%	15,006 $1.27 Billion
Q1 2022 Aug 16, 2024	SELL	$80.11 - $90.62 $290,158 - $328,225	-3,622 Reduced 21.47%	13,250 $1.16 Billion
Q4 2021 Aug 16, 2024	SELL	$79.7 - $88.13 $31,481 - $34,811	-395 Reduced 2.29%	16,872 $1.48 Billion
Q3 2021 Aug 16, 2024	BUY	$81.78 - $95.14 $688,342 - $800,793	8,417 Added 95.11%	17,267 $1.41 Billion
Q2 2021 Aug 16, 2024	BUY	$85.24 - $94.15 $304,562 - $336,397	3,573 Added 16.67%	25,010 $2.28 Billion
Q1 2021 Aug 16, 2024	SELL	$83.5 - $98.47 $118,486 - $139,728	-1,419 Reduced 6.21%	21,437 $1.83 Billion
Q4 2020 Aug 16, 2024	SELL	$78.07 - $94.43 $95,869 - $115,960	-1,228 Reduced 5.1%	22,856 $2.16 Billion
Q3 2020 Aug 16, 2024	SELL	$82.14 - $91.0 $744,763 - $825,097	-9,067 Reduced 27.35%	24,084 $2.09 Billion
Q2 2020 Aug 16, 2024	BUY	$80.93 - $91.1 $1.02 Million - $1.15 Million	12,619 Added 61.46%	33,151 $2.9 Billion
Q1 2020 Aug 16, 2024	BUY	$70.67 - $99.01 $226,709 - $317,624	3,208 Added 18.52%	20,532 $1.69 Billion
Q4 2019 Aug 16, 2024	BUY	$84.35 - $95.37 $714,781 - $808,165	8,474 Added 95.75%	17,324 $1.64 Billion

Others Institutions Holding NVS

# of Institutions

1,558

Shares Held

136M

Call Options Held

1.72M

Put Options Held

1.7M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $285B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.

Account

Td Private Client Wealth LLC Novartis Ag Transaction History